Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

HLA markers and prediction of clinical course and outcome in rheumatoid arthritis

Wagner, Ulf, Kaltenhäuser, Sylke, Sauer, Heidemarie, Arnold, Sybille, Seidel, Wolfram, Häntzschel, Holm, Kalden, Joachim R., Wassmuth, Ralf · 1997 · Arthritis & Rheumatism

Abstract

Objective. To evaluate HLA markers as early prognostic factors for disease severity in rheumatoid arthritis (RA). Methods. HLA genotyping was carried out in a retrospective analysis of 66 RA patients and in a prospective study of 55 RA patients and 87 healthy controls using polymerase chain reaction‐based methods for HLA‐DRB1 specificities, DR4 alleles, and their linked DQB1 alleles, as well as HLA‐B27. The clinical course of RA was assessed by clinical and radiologic scores. The impact of HLA markers was evaluated by epidemiologic means in addition to modeling using multiple logistic regression analysis. Results. Shared epitope‐positive (HVR3+) DR4 alleles and the HVR3 amino acid cassette QKRAA were associated with RA in both longstanding (relative risk [RR] 3.34 and 3.19) and recent‐onset (RR 2.1 and 2.37) RA. In longstanding RA, radiologic evidence of severe joint destruction (Larsen score > 1.62) was seen more often in HVR3 shared epitope‐positive patients than in epitope‐negative patients (odds ratio [OR] = 25.67, X2 = 13.59, P = 0.0003). Moreover, rank sum analysis of Larsen indices indicated significantly higher ranking for the presence of the RA‐associated HVR3 cassettes (QKRAA, QRRAA) when expressed on a DR4 allele (P < 0.0001). In the prospective study, DR4‐positive patients had a significantly increased risk (OR = 13.75, P = 0.00083) of developing bony erosions. In addition, HVR3 epitope‐positive DR4‐positive individuals had significantly higher Larsen indices than did epitope‐negative patients (P = 0.0083). In particular, the presence of the HVR3 epitope on DR4 resulted in an increased a posteriori likelihood (0.91) of developing early erosive disease compared with an a priori risk of 0.62. Conversely, the likelihood decreased to a minimum of 0.35 when the HVR3 epitope was absent. Conclusion. While the contribution of HLA typing to establishing the diagnosis of RA is limited, HLA‐DR genotyping and DR4 subtype determination provide valuable markers for the prognosis of joint destruction in RA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.1780400219

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 166

Metadata

Authors
Wagner, U., Kaltenhäuser, S., Sauer, H., Arnold, S., Seidel, W., Häntzschel, H., Kalden, J. R., & Wassmuth, R.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
1997-02
Volume
40
Issue
2
Pages
341-351
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2043547351
Cited by
166
References
1
FWCI
9.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.1780400219
The paper
Wagner, U., Kaltenhäuser, S., Sauer, H., Arnold, S., Seidel, W., Häntzschel, H., Kalden, J. R., & Wassmuth, R. (1997). HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780400219

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.